Katie Cox - Guardion Health Chief Officer
GHSI Stock | USD 8.00 0.14 1.72% |
Executive
Katie Cox is Chief Officer of Guardion Health Sciences
Age | 54 |
Address | 2925 Richmond Avenue, Houston, TX, United States, 77098 |
Phone | 800 873 5141 |
Web | https://www.guardionhealth.com |
Guardion Health Management Efficiency
The company has return on total asset (ROA) of (0.1466) % which means that it has lost $0.1466 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0148 %, meaning that it created $0.0148 on every $100 dollars invested by stockholders. Guardion Health's management efficiency ratios could be used to measure how well Guardion Health manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Guardion Health's Return On Tangible Assets are increasing as compared to previous years. The Guardion Health's current Return On Assets is estimated to increase to 0.01, while Return On Capital Employed is forecasted to increase to (0.35). As of now, Guardion Health's Return On Assets are increasing as compared to previous years. The Guardion Health's current Asset Turnover is estimated to increase to 1.08, while Total Assets are projected to decrease to under 10.1 M.Similar Executives
Showing other executives | EXECUTIVE Age | ||
Samantha Widdicombe | Biofrontera | N/A | |
Thomas Pearl | Organogenesis Holdings | N/A | |
Kara Morley | Lifecore Biomedical | N/A | |
Gene Esq | Shuttle Pharmaceuticals | N/A | |
Darren Hieber | Lifecore Biomedical | N/A | |
Ernest Toth | Aquestive Therapeutics | 65 | |
William CPA | Organogenesis Holdings | N/A | |
Carl MD | Aquestive Therapeutics | 54 | |
Stephen Wargacki | Aquestive Therapeutics | 46 | |
Kenneth Marshall | Aquestive Therapeutics | 65 | |
Cassie Jung | Aquestive Therapeutics | 45 | |
MBA MD | Aquestive Therapeutics | 66 | |
Alycia Torres | Biofrontera | N/A | |
Steve Laninga | Lifecore Biomedical | N/A | |
Jackie Klecker | Lifecore Biomedical | N/A | |
Matt Augustson | Lifecore Biomedical | N/A | |
Lori McKenna | Cyclo Therapeutics | N/A | |
Daniel JD | Biofrontera | N/A | |
Karen FFPM | Cyclo Therapeutics | N/A | |
John Shulman | Petros Pharmaceuticals | 61 | |
Jon MBA | Biofrontera | N/A |
Management Performance
Return On Equity | 0.0148 | ||||
Return On Asset | -0.15 |
Guardion Health Sciences Leadership Team
Elected by the shareholders, the Guardion Health's board of directors comprises two types of representatives: Guardion Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Guardion. The board's role is to monitor Guardion Health's management team and ensure that shareholders' interests are well served. Guardion Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Guardion Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Robert Weingarten, Independent Secretary | ||
Janet Hall, President CEO | ||
Jeffrey Benjamin, Chief Officer | ||
Craig Sheehan, Chief Officer | ||
Bret Scholtes, CEO Pres | ||
Katie Cox, Chief Officer |
Guardion Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Guardion Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0148 | ||||
Return On Asset | -0.15 | ||||
Profit Margin | 0.01 % | ||||
Operating Margin | (0.24) % | ||||
Current Valuation | 3.91 M | ||||
Shares Outstanding | 1.28 M | ||||
Shares Owned By Insiders | 19.82 % | ||||
Shares Owned By Institutions | 17.50 % | ||||
Number Of Shares Shorted | 148.23 K | ||||
Price To Earning | (0.71) X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardion Health Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Guardion Stock analysis
When running Guardion Health's price analysis, check to measure Guardion Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardion Health is operating at the current time. Most of Guardion Health's value examination focuses on studying past and present price action to predict the probability of Guardion Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardion Health's price. Additionally, you may evaluate how the addition of Guardion Health to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
Is Guardion Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardion Health. If investors know Guardion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardion Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.12 | Revenue Per Share 9.638 | Quarterly Revenue Growth 0.077 | Return On Assets (0.15) | Return On Equity 0.0148 |
The market value of Guardion Health Sciences is measured differently than its book value, which is the value of Guardion that is recorded on the company's balance sheet. Investors also form their own opinion of Guardion Health's value that differs from its market value or its book value, called intrinsic value, which is Guardion Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardion Health's market value can be influenced by many factors that don't directly affect Guardion Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardion Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardion Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardion Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.